Kemofarmacija

Last update: 23 days ago

Pharmaceuticals
Slovenia Its 16 main executives

Recent executive movements at McKesson

Bansi Nagji, Executive Vice President, Chief Strategy and Business Development Officer, will leave the company on Mar. 31, 2020  (news posted on March 24 2020).
Nancy Flores will join the company as Executive Vice President, Chief Information Officer and Chief Technology Officer on Jan. 13, 2020  (news posted on December 10 2019).
Kathy McElligott, Executive Vice President, Chief Informationand Chief Technology Officer, will leave the company in Jan. 2020  (news posted on December 10 2019).

Create an alert
to follow the executive moves at Kemofarmacija.

Latest M&A news in Pharmaceuticals.

Zyla Life Sciences and Assertio Therapeutics have announced they will merge (posted on Mar 17, 2020).
Dermapharm has announced the acquisition of Allergopharma (posted on Feb 19, 2020).
Qualigen has announced the acquisition of Ritter Pharmaceuticals (posted on Jan 21, 2020).

Latest news about Kemofarmacija

Kemofarmacija on Wikipedia, Google News & Yahoo Finance

Kemofarmacija on LinkedIn, Twitter & YouTube

Kemofarmacija has 1,978 competitors including Johnson & Johnson (United States (USA)), Sanofi (France) and Roche (Switzerland). Kemofarmacija is owned by McKesson Europe.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.